An ongoing shortage of albuterol, a critical medicine for treating breathing problems, has intensified following the shutdown of a major supplier to U.S. hospitals. STAQ Pharma, a hospital-owned 503B outsourcing supplier,…

With February’s sudden shutdown of an Illinois manufacturing plant, STAQ’s production of Albuterol may be in even higher demand, according to a recent article by The Washington Post.

Albuterol — one of the most essential medications for pediatric patients — has been facing a critical shortage since June 2022. In partnership with Children’s Hospital Colorado (CHC), STAQ has been…

Being able to make a positive impact on the critical Albuterol shortage is one of the reasons we got into this business. The “A” in STAQ stands for availability, after all.

The results of STAQ’s partnership with Angels for Change to address shortages of two critical medications for children are not going unnoticed. Watch CNN’s powerful story and/or read the article here.

As a direct result of STAQ’s partnership with Angels for Change, in just the first 6 months, more than 500,000 pediatric patients have had been protected from a shortage of Potassium Chloride…